Taiwan Biomaterial Co., Ltd. (TPEX:6649)
73.80
+3.30 (4.68%)
Oct 9, 2025, 1:30 PM CST
Taiwan Biomaterial Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 235.42 | 205.34 | 171.68 | 183.15 | 91.65 | 70.81 | Upgrade |
Short-Term Investments | 107.5 | 107.5 | 132.5 | 149.5 | 61 | 137.9 | Upgrade |
Cash & Short-Term Investments | 342.92 | 312.84 | 304.18 | 332.65 | 152.65 | 208.71 | Upgrade |
Cash Growth | 18.16% | 2.85% | -8.56% | 117.92% | -26.86% | -48.67% | Upgrade |
Accounts Receivable | 14.78 | 11.92 | 14.39 | 16.04 | 2.4 | 6.11 | Upgrade |
Other Receivables | 0.57 | 0.6 | 0.5 | 0.25 | 0.01 | 6.35 | Upgrade |
Receivables | 15.35 | 12.52 | 14.89 | 16.29 | 2.41 | 12.45 | Upgrade |
Inventory | 32.25 | 40.59 | 48.43 | 17.8 | 9.98 | 5.92 | Upgrade |
Prepaid Expenses | 8.21 | 5.35 | 4.04 | 7.75 | 11.1 | 12.31 | Upgrade |
Total Current Assets | 398.72 | 371.3 | 371.54 | 374.49 | 176.14 | 239.39 | Upgrade |
Property, Plant & Equipment | 317.63 | 325.37 | 336.39 | 351.49 | 363.35 | 317.6 | Upgrade |
Long-Term Investments | - | 0.13 | 0.09 | 0.06 | 0.04 | 0.04 | Upgrade |
Other Intangible Assets | 1.23 | 1.28 | 1.58 | 2.37 | 1.98 | 2.02 | Upgrade |
Other Long-Term Assets | 6.51 | 6.47 | 6.68 | 6.91 | 12.28 | 13.42 | Upgrade |
Total Assets | 724.09 | 704.56 | 716.28 | 735.31 | 553.79 | 572.47 | Upgrade |
Accounts Payable | 5.19 | 4.7 | 8.25 | 3.62 | 6.65 | 1.22 | Upgrade |
Accrued Expenses | 7.46 | 12.3 | 14.02 | 11.92 | 12.6 | 14.65 | Upgrade |
Current Portion of Leases | 4.43 | 4.4 | 5.18 | 7.22 | 6.88 | 2.24 | Upgrade |
Current Income Taxes Payable | - | - | 1.1 | - | - | - | Upgrade |
Current Unearned Revenue | 0.65 | 0.47 | - | - | - | 0.15 | Upgrade |
Other Current Liabilities | 3.31 | 3.93 | 4.33 | 4.49 | 37.37 | 10.9 | Upgrade |
Total Current Liabilities | 21.04 | 25.81 | 32.87 | 27.25 | 63.5 | 29.15 | Upgrade |
Long-Term Leases | 50.37 | 52.59 | 55.52 | 61.29 | 67.04 | 73.92 | Upgrade |
Other Long-Term Liabilities | - | - | - | 0.35 | 0.35 | 0.35 | Upgrade |
Total Liabilities | 71.41 | 78.4 | 88.38 | 88.89 | 130.89 | 103.42 | Upgrade |
Common Stock | 420 | 420 | 420 | 420 | 330 | 330 | Upgrade |
Additional Paid-In Capital | 192.67 | 192.67 | 192.67 | 192.67 | 265.98 | 265.71 | Upgrade |
Retained Earnings | 40.02 | 13.49 | 15.23 | 33.76 | -174.11 | -126.67 | Upgrade |
Comprehensive Income & Other | - | - | - | - | 1.03 | - | Upgrade |
Shareholders' Equity | 652.68 | 626.16 | 627.89 | 646.42 | 422.89 | 469.05 | Upgrade |
Total Liabilities & Equity | 724.09 | 704.56 | 716.28 | 735.31 | 553.79 | 572.47 | Upgrade |
Total Debt | 54.8 | 56.99 | 60.7 | 68.51 | 73.92 | 76.16 | Upgrade |
Net Cash (Debt) | 288.12 | 255.85 | 243.48 | 264.14 | 78.73 | 132.56 | Upgrade |
Net Cash Growth | 24.78% | 5.08% | -7.82% | 235.51% | -40.61% | -59.90% | Upgrade |
Net Cash Per Share | 6.86 | 6.09 | 5.80 | 6.46 | 2.39 | 4.02 | Upgrade |
Filing Date Shares Outstanding | 42 | 42 | 42 | 42 | 33 | 33 | Upgrade |
Total Common Shares Outstanding | 42 | 42 | 42 | 42 | 33 | 33 | Upgrade |
Working Capital | 377.68 | 345.5 | 338.67 | 347.24 | 112.64 | 210.25 | Upgrade |
Book Value Per Share | 15.54 | 14.91 | 14.95 | 15.39 | 12.81 | 14.21 | Upgrade |
Tangible Book Value | 651.46 | 624.88 | 626.31 | 644.06 | 420.92 | 467.03 | Upgrade |
Tangible Book Value Per Share | 15.51 | 14.88 | 14.91 | 15.33 | 12.76 | 14.15 | Upgrade |
Buildings | - | 267.85 | 267.85 | 267.85 | - | - | Upgrade |
Machinery | - | 53.51 | 49.68 | 50.71 | 48.87 | 31.7 | Upgrade |
Construction In Progress | - | - | - | - | 267.85 | 229.99 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.